Technical Analysis for GSK - Glaxosmithkline Plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Flat | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.00% | |
| MACD Bullish Signal Line Cross | Bullish | 0.00% | |
| Cup with Handle | Other | 0.00% | |
| Doji - Bearish? | Reversal | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| 20 DMA Resistance | Bearish | 0.70% | |
| Slingshot Bearish | Bearish Swing Setup | 0.70% | |
| Stochastic Buy Signal | Bullish | 0.70% | |
| Pocket Pivot | Bullish Swing Setup | 0.70% |
| Alert | Time |
|---|---|
| 20 DMA Support | about 12 hours ago |
| 20 DMA Resistance | about 13 hours ago |
| Rose Above Previous Day's High | about 17 hours ago |
| Rose Above 20 DMA | about 17 hours ago |
| Up 1% | about 17 hours ago |
Get a Trading Sidekick!
Glaxosmithkline Plc Description
GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines, vaccines and consumer healthcare products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. The Consumer Healthcare business develops and markets products in Wellness, Oral health, Nutrition and Skin health categories. Its product portfolio includes Adartrel, Bexsero, Daraprim and Quinvaxem. Its brands include Panadol, abreva, polident and physiogel.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Health Healthcare Consumer Biotechnology Pharmaceutical Medicine Pharmaceuticals Disease Diseases Oncology Nutrition Skin Pharmacy Pharmaceutical Industry Smith Hiv Infectious Diseases Infectious Disease Rare Diseases Respirator Vaccine Axe Healthcare Products Infectious Respiratory Disease Respiratory Diseases Inflammation Pharmacology Consumer Healthcare Glaxosmithkline Consumer Healthcare Products Glaxosmithkline Pharmaceuticals Ltd
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1725.6438 |
| 52 Week Low | 1302.2105 |
| Average Volume | 4,878,206 |
| 200-Day Moving Average | 1505.51 |
| 50-Day Moving Average | 1658.72 |
| 20-Day Moving Average | 1641.84 |
| 10-Day Moving Average | 1621.05 |
| Average True Range | 27.31 |
| RSI (14) | 53.05 |
| ADX | 21.94 |
| +DI | 25.95 |
| -DI | 26.69 |
| Chandelier Exit (Long, 3 ATRs) | 1631.07 |
| Chandelier Exit (Short, 3 ATRs) | 1656.93 |
| Upper Bollinger Bands | 1713.81 |
| Lower Bollinger Band | 1569.86 |
| Percent B (%b) | 0.56 |
| BandWidth | 8.77 |
| MACD Line | -11.07 |
| MACD Signal Line | -11.21 |
| MACD Histogram | 0.1425 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1679.51 | ||||
| Resistance 3 (R3) | 1678.01 | 1667.00 | 1674.75 | ||
| Resistance 2 (R2) | 1667.00 | 1659.74 | 1667.75 | 1673.17 | |
| Resistance 1 (R1) | 1659.00 | 1655.26 | 1663.00 | 1660.50 | 1671.59 |
| Pivot Point | 1648.00 | 1648.00 | 1650.00 | 1648.75 | 1648.00 |
| Support 1 (S1) | 1640.00 | 1640.74 | 1644.00 | 1641.50 | 1630.41 |
| Support 2 (S2) | 1628.99 | 1636.25 | 1629.75 | 1628.83 | |
| Support 3 (S3) | 1620.99 | 1628.99 | 1627.25 | ||
| Support 4 (S4) | 1622.49 |
